Remodeling as an End-Point in Heart Failure Therapy

By Cohn Jay  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 7-8

Springer Publishing Company

Access to resources Recommend Favorite

Immunosuppressive Therapy for Heart Failure: A Guide to Patient Selection

By Nowalany-Kozielska E.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 321-324

Adis International

Access to resources Recommend Favorite

Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure

By Suzuki George   Khanal Sanjaya   Rastogi Sharad   Morita Hideaki   Mishima Takayuki   Anagnostopoulos Petros   Nass Omar   Sharov Victor   Tanhehco Elaine   Goldstein Sidney   Sabbah Hani  

Cardiovascular Drugs and Therapy, Vol. 21, Iss. 1, 2007-02 ,pp. : 29-36

Springer Publishing Company

Access to resources Recommend Favorite

Modulation of Fatty Acids Oxidation in Heart Failure by Selective Pharmacological Inhibition of 3-Ketoacyl Coenzyme-A Thiolase

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 190-196

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction

By Sanganalmath Santosh K.   Barta Judit   Takeda Nobuakira   Kumamoto Hideo   Dhalla Naranjan S.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 4, 2008-04 ,pp. : 180-189

NRC Research Press

Access to resources Recommend Favorite